comprehensive -WSS

comprehensive

author：fashion 2025-08-12 08:30:26 - browse：2863

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： As pharma fights Medicare drug negotiation, hospitals, docs silent

leisure time

WSS

Australia’s approach to dialysis celebrates life

Digital health funding stays low as a new reality sets in

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

EU fines Illumina $475 million over Grail acquisition

One Duchenne patient's bittersweet hope for new treatment

hotspot

comprehensive

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Women's World Cup brings attention to abuse in soccer

In age of alternative facts, a scholarly course on calling out crap

Diversity in medical illustrations gets boost from Chidiebere Ibe

Continuity nursing helped my family in our darkest PICU moments

FDA panel gives mixed vote on blood pressure devices

The high cost of giving birth even with insurance

As pharma fights Medicare drug negotiation, hospitals, docs silent

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Diversity in medical illustrations gets boost from Chidiebere Ibe

explore

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

FDA panel gives mixed vote on blood pressure devices

Antibody drugs appear effective. Now can we make enough of them?

Departing Stanford president retracts two papers

Neuroscience startup Neumora files for IPO

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

hotspot

explore

leisure time

focus